← All Day One Biopharmaceuticals, INC filings

Day One Biopharmaceuticals, INC Form 4 insider transactions

NASDAQ
DAWN
Day One Biopharmaceuticals, INC
Form 4: Day One Biopharmaceuticals Executive Sells 10,000 Shares Under 10b5-1 Plan
Samuel C. Blackman, Head of R&D at Day One Biopharmaceuticals, sold 10,000 shares of common stock at an average price of $16.0163 per share on April 18, 2024, under a pre-arranged trading plan.
NASDAQ
DAWN
Day One Biopharmaceuticals, INC
Form 4: Day One Biopharmaceuticals Executive Sells 10,000 Shares
Samuel C. Blackman, Head of R&D at Day One Biopharmaceuticals, sold 10,000 shares of common stock on March 25, 2024, according to a Form 4 filing.
NASDAQ
DAWN
Day One Biopharmaceuticals, INC
Form 4: Day One Biopharmaceuticals Executive Samuel Blackman Sells 30,000 Shares
Samuel Blackman, Head of R&D at Day One Biopharmaceuticals, sold 30,000 shares of common stock on March 11, 2024, at a weighted average price of $15.2438 per share.
NASDAQ
DAWN
Day One Biopharmaceuticals, INC
Form 4: Day One Biopharmaceuticals Executive Samuel Blackman Sells 20,000 Shares
Samuel Blackman, Head of R&D at Day One Biopharmaceuticals, sold 20,000 shares of common stock at an average price of $16.1083 on February 27, 2024, under a pre-arranged Rule 10b5-1 trading plan.